The Employees’ State Insurance Corporation (ESIC), on November 11, 2026, has issued a communication regarding the utilisation of slow-moving, non-moving and near-expiry medicines available at the hospital. The communication provides a list of 21 medicines and consumables, along with their available quantities, batch numbers and expiry dates, for redistribution and utilisation by other ESIC medical institutions, hospitals and dispensaries.
The listed medicines include Carvimen 10 mg, Pirfinex, Losark H tablets, Moximac 400 mg, Aprecap Kit, Rucaparib, Sofosbuvir, Doxorubicin, Leucovorin, 5-FU, Rybravent and other medicines, with certain batches approaching expiry as early as November 30, 2026. Accordingly, Deans, Medical Superintendents and Heads of Departments have been requested to raise indents for the required medicines and send the same through email so that the available stock can be utilised by their respective hospitals and dispensaries.
The communication is intended to facilitate optimal utilisation of available pharmaceutical stock and minimise wastage due to expiry. Concerned ESIC institutions should review their requirements and submit indents for suitable medicines, taking into account the available quantities, batch details and expiry dates.
[Letter No. E-330875-115/U/16/30/NSQ/2023]
